Patents by Inventor Nora Dognitz

Nora Dognitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8235974
    Abstract: A method for hair removal from a skin area by selective photo-inactivation of the pilo-sebaceous apparatus using derivatives of ALA with alkylene-glycol chains. Selectivity of the method is further enhanced by treatment of the epidermis by agents reducing PpIX levels in the epidermis. Side effects are diminished by using short drug/light intervals.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 7, 2012
    Assignee: Ecole Polytechnique Federale de Lausanne (EPFL)
    Inventors: Georges Wagnieres, Norbert Lange, Nora Dögnitz, Denis Salomon, Hubert Van Den Bergh
  • Publication number: 20080039921
    Abstract: A balloon catheter is provided for the implantation of a stent in a mammalian duct or cavity, comprising an elongate distal section and an expandable first balloon accommodating the section, further comprising means for the supply of a pressure medium for the expansion of the balloon, and means for heating the pressure medium, the catheter being provided with an elongate stent mounted onto the balloon. The catheter contains second means for establishing outwardly directed expansion of the stent at a sight or location selected from the two ends of the stent so that the stent will remain in position as implanted after removal of the catheter from the duct or cavity; and a method for the implantation of a stent in a human prostatic urethra.
    Type: Application
    Filed: June 9, 2005
    Publication date: February 14, 2008
    Applicant: WALLSTEN MEDICAL S.A.
    Inventors: Hans Wallsten, Nora Dognitz, Jerome Duc
  • Publication number: 20050124984
    Abstract: A method for hair removal from a skin area by selective photo-inactivation of the pilo-sebaceous apparatus using derivatives of ALA with alkylene-glycol chains. Selectivity of the method is further enhanced by treatment of the epidermis by agents reducing PpIX levels in the epidermis. Side effects are diminished by using short drug/light intervals.
    Type: Application
    Filed: November 15, 2002
    Publication date: June 9, 2005
    Inventors: Georges Wagnieres, Norbert Lange, Nora Dognitz, Denis Salomon, Hubert Van Den Bergh